3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
6
Colonic Neoplasms
5
Pancreatic Neoplasms
3
Pain, Postoperative
3
Inflammatory Bowel Diseases
3
Diverticulitis
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Male Urogenital Diseases
2
Leiomyoma
2
Inflammation
2
Carcinoma, Non-Small-Cell Lung
2
Abdominal Cancer
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Skin Neoplasms
1
Shoulder Pain
1
Respiration Disorders
1
Psychological Well-Being
1
Postoperative Complications
1
Post-thoracotomy Pain Syndrome
1
Neoplasms
1
Mouth Neoplasms
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Interventions
Cisplatin
274
pembrolizumab
229
Radiotherapy
166
Cetuximab
163
Carboplatin
122
Docetaxel
109
Paclitaxel
94
Fluorouracil
94
Nivolumab
84
Radiotherapy, Intensity-Modulated
78
Magnetic Resonance Spectroscopy
39
durvalumab
35
Radiation
32
Surgical Procedures, Operative
31
Drug Therapy
30
Radiosurgery
25
Erlotinib Hydrochloride
25
Biopsy
25
Albumin-Bound Paclitaxel
24
130-nm albumin-bound paclitaxel
24
Taxes
23
Platinum
22
Specimen Handling
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Capecitabine
19
tremelimumab
18
Ipilimumab
18
Gemcitabine
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Cell Carcinoma of Head and Neck
×
Tea
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled